Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02041481
Title MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center, National Cancer Institute (NCI), Novartis
Indications

colorectal cancer

rectum cancer

colon cancer

Therapies

Binimetinib + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.